Lars Berglund

19.4k total citations · 2 hit papers
249 papers, 12.7k citations indexed

About

Lars Berglund is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Lars Berglund has authored 249 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Surgery, 91 papers in Endocrinology, Diabetes and Metabolism and 58 papers in Molecular Biology. Recurrent topics in Lars Berglund's work include Lipoproteins and Cardiovascular Health (87 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (64 papers) and Cancer, Lipids, and Metabolism (32 papers). Lars Berglund is often cited by papers focused on Lipoproteins and Cardiovascular Health (87 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (64 papers) and Cancer, Lipids, and Metabolism (32 papers). Lars Berglund collaborates with scholars based in United States, Sweden and Denmark. Lars Berglund's co-authors include Peter Stenvinkel, Olof Heimbürger, Furcy Paultre, Ulf Diczfalusy, Erdembileg Anuurad, Byambaa Enkhmaa, Torben E. Petersen, Tomas Jogestrand, Peter Henriksson and Rajasekhar Ramakrishnan and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Lars Berglund

248 papers receiving 12.2k citations

Hit Papers

Strong association betwee... 1999 2026 2008 2017 1999 2012 400 800 1.2k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lars Berglund 4.7k 3.3k 2.7k 2.2k 2.2k 249 12.7k
James D. Best 3.7k 0.8× 5.2k 1.6× 3.0k 1.1× 2.4k 1.1× 1.8k 0.8× 241 13.2k
Anton F. H. Stalenhoef 6.3k 1.3× 4.1k 1.2× 2.8k 1.0× 2.9k 1.3× 1.0k 0.5× 240 13.3k
Dimitri P. Mikhailidis 3.2k 0.7× 4.6k 1.4× 2.0k 0.8× 3.7k 1.6× 2.1k 0.9× 372 14.3k
Moses Elisaf 7.6k 1.6× 7.0k 2.1× 3.5k 1.3× 3.7k 1.6× 2.1k 1.0× 692 21.3k
Muredach P. Reilly 4.0k 0.9× 2.5k 0.8× 4.9k 1.8× 4.2k 1.9× 2.9k 1.3× 302 18.5k
Peter Nilsson‐Ehle 2.1k 0.4× 2.8k 0.8× 1.8k 0.7× 1.7k 0.7× 1.6k 0.7× 246 9.5k
Allan D. Sniderman 7.8k 1.7× 6.5k 2.0× 2.3k 0.8× 4.7k 2.1× 2.7k 1.2× 292 16.4k
David Sullivan 5.5k 1.2× 3.6k 1.1× 2.0k 0.7× 2.5k 1.1× 1.1k 0.5× 211 11.8k
Raúl D. Santos 5.9k 1.3× 3.6k 1.1× 1.4k 0.5× 3.5k 1.5× 1.6k 0.7× 375 12.8k
Bernhard O. Boehm 3.0k 0.6× 3.7k 1.1× 2.8k 1.1× 1.5k 0.7× 1.3k 0.6× 307 13.7k

Countries citing papers authored by Lars Berglund

Since Specialization
Citations

This map shows the geographic impact of Lars Berglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Berglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Berglund more than expected).

Fields of papers citing papers by Lars Berglund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Berglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Berglund. The network helps show where Lars Berglund may publish in the future.

Co-authorship network of co-authors of Lars Berglund

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Berglund. A scholar is included among the top collaborators of Lars Berglund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Berglund. Lars Berglund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Stanhope, Kimber L., Wei Zhang, Muhammad Arif Khan, et al.. (2024). Lipoprotein(a) and diet: consuming sugar-sweetened beverages lowers lipoprotein(a) levels in obese and overweight adults. Journal of Lipid Research. 65(8). 100588–100588. 1 indexed citations
3.
Enkhmaa, Byambaa, et al.. (2011). Lipoprotein(a): Genotype–Phenotype Relationship and Impact on Atherogenic Risk. Metabolic Syndrome and Related Disorders. 9(6). 411–418. 32 indexed citations
4.
Öztürk, Zeynep, Byambaa Enkhmaa, Neil S. Shachter, Lars Berglund, & Erdembileg Anuurad. (2010). Integrated Role of Two Apoliprotein E Polymorphisms on Apolipoprotein B Levels and Coronary Artery Disease in a Biethnic Population. Metabolic Syndrome and Related Disorders. 8(6). 531–538. 9 indexed citations
5.
Anuurad, Erdembileg, et al.. (2009). Human Immunodeficiency Virus and Highly Active Antiretroviral Therapy–Associated Metabolic Disorders and Risk Factors for Cardiovascular Disease. Metabolic Syndrome and Related Disorders. 7(5). 401–409. 50 indexed citations
6.
Asmuth, David M., Ted Wun, Eric García, et al.. (2009). UC Davis CTSA: Coming of Age. Clinical and Translational Science. 2(2). 98–101. 2 indexed citations
7.
Wu, Henry, Lars Berglund, Clarito Dimayuga, et al.. (2004). High lipoprotein(a) levels and small apolipoprotein(a) sizes are associated with endothelial dysfunction in a multiethnic cohort. Journal of the American College of Cardiology. 43(10). 1828–1833. 52 indexed citations
8.
Shea, Steven A., Eve Aymong, Patricia Zybert, et al.. (2003). Fasting Plasma Insulin Modulates Lipid Levels and Particle Sizes in 2‐ to 3‐Year‐Old Children. Obesity Research. 11(6). 709–721. 14 indexed citations
9.
Hyson, Dianne A., John C. Rutledge, & Lars Berglund. (2003). Postprandial lipemia and cardiovascular disease. Current Atherosclerosis Reports. 5(6). 437–444. 128 indexed citations
10.
Humphries, Steve E., Lars Berglund, Carmen R. Isasi, et al.. (2002). Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers Study.. PubMed. 12(4). 163–72. 18 indexed citations
11.
Sacco, Ralph L., Richard Benson, Douglas E. Kargman, et al.. (2001). High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly. JAMA. 285(21). 2729–2729. 236 indexed citations
12.
Weryński, Andrzej, Zbigniew Nahorski, Bo Angelin, Lars Berglund, & Mats Eriksson. (2000). Kinetic analysis of LDL apoB transport and metabolism in non-steady states. Control and Cybernetics. 29(1). 405–425. 1 indexed citations
13.
Couch, Sarah C., Carmen R. Isasi, Wahida Karmally, et al.. (2000). Predictors of postprandial triacylglycerol response in children: the Columbia University Biomarkers Study. American Journal of Clinical Nutrition. 72(5). 1119–1127. 25 indexed citations
14.
Berglund, Lars, Elizabeth Oliver, Nelson Fontanez, et al.. (1999). HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects. American Journal of Clinical Nutrition. 70(6). 992–1000. 54 indexed citations
15.
Barth, Jay, Richard J. Deckelbaum, Thomas J. Starc, et al.. (1999). Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: Relationship to lipoprotein (a) and low-density lipoprotein cholesterol levels. Journal of Laboratory and Clinical Medicine. 133(3). 237–244. 12 indexed citations
16.
Stenvinkel, Peter, Olof Heimbürger, Catherine H. Tuck, & Lars Berglund. (1998). Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney International. 53(5). 1336–1342. 69 indexed citations
17.
Pillarisetti, Sivaram, et al.. (1997). Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.. Journal of Clinical Investigation. 100(4). 867–874. 91 indexed citations
18.
Andersen, Mikkel Holmen, et al.. (1996). Characterization of Glycoprotein PAS‐6/7 from Membranes of Bovine Milk Fat Globules. European Journal of Biochemistry. 240(3). 628–636. 124 indexed citations
19.
Ericsson, S, et al.. (1991). Gemfibrozil in familial combined hyperlipidaemia: effect of added low‐dose cholestyramine on plasma and biliary lipids. European Journal of Clinical Investigation. 21(3). 344–349. 12 indexed citations
20.
Berglund, Lars, Bo Angelin, R. Hultcrantz, et al.. (1990). Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis.. Gut. 31(8). 899–904. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026